Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2024-05-07 | Troendle August J. | CEO | Sell | 52,404 | $403.20 | $21,129,346.92 | -3.4% | → |
| 2024-05-02 | Troendle August J. | CEO | Sell | 16,330 | $401.33 | $6,553,671.28 | -1.0% | → |
| 2024-04-30 | Troendle August J. | CEO | Sell | 16,930 | $400.65 | $6,782,987.06 | -1.1% | → |
| 2024-03-15 | BURWIG SUSAN E | Exec. VP, Operations | Sell | 102 | $403.00 | $41,106.00 | -0.7% | → |
| 2024-03-14 | Keating Ashley M. | Director | Sale+OE | 250 | $409.87 | $102,467.50 | -50.0% | → |
| 2024-03-08 | Troendle August J. | CEO | Sell | 200,000 | $411.61 | $82,321,250.00 | -1.4% | → |
| 2024-03-08 | Medpace Investors, LLC | 10% Owner | Sell | 200,000 | $411.61 | $82,321,250.00 | -1.4% | → |
| 2024-03-07 | Keating Ashley M. | Director | Sale+OE | 472 | $415.00 | $195,880.00 | -100% | → |
| 2024-03-05 | Troendle August J. | CEO | Sell | 100,000 | $402.91 | $40,291,000.00 | -1.0% | → |
| 2024-03-05 | Medpace Investors, LLC | 10% Owner | Sell | 100,000 | $402.91 | $40,291,000.00 | -1.0% | → |
| 2024-03-04 | GEIGER JESSE J | President | Sale+OE | 22,321 | $403.03 | $8,996,032.63 | -85.4% | → |
| 2024-03-01 | Medpace Investors, LLC | 10% Owner | Sell | 100,000 | $400.25 | $40,024,600.00 | -1.0% | → |
| 2024-03-01 | Troendle August J. | CEO | Sell | 100,000 | $400.25 | $40,024,600.00 | -1.0% | → |
| 2024-03-01 | EWALD STEPHEN P | General Counsel & Corp. Secy. | Sell | 1,513 | $395.19 | $597,922.82 | -5.3% | → |
| 2024-02-29 | GEIGER JESSE J | President | Sell | 2,558 | $393.51 | $1,006,585.79 | -40.1% | → |
| 2024-02-28 | Keating Ashley M. | Director | Sale+OE | 500 | $405.00 | $202,500.00 | -100% | → |
| 2024-02-28 | Medpace Investors, LLC | 10% Owner | Sell | 100,000 | $403.01 | $40,300,500.00 | -1.0% | → |
| 2024-02-28 | Troendle August J. | CEO | Sell | 100,000 | $403.01 | $40,300,500.00 | -1.0% | → |
| 2024-02-26 | Keating Ashley M. | Director | Sale+OE | 500 | $404.29 | $202,146.64 | -66.3% | → |
| 2024-02-26 | Troendle August J. | CEO | Sell | 156,928 | $401.07 | $62,938,688.64 | -1.5% | → |
| 2024-02-26 | Medpace Investors, LLC | 10% Owner | Sell | 156,928 | $401.07 | $62,938,688.64 | -1.5% | → |
| 2024-02-22 | Medpace Investors, LLC | 10% Owner | Sell | 136,012 | $392.66 | $53,406,441.28 | -1.2% | → |
| 2024-02-22 | Troendle August J. | CEO | Sell | 136,012 | $392.66 | $53,406,441.28 | -1.2% | → |
| 2024-02-20 | Troendle August J. | CEO | Sell | 63,988 | $390.58 | $24,992,323.32 | -0.6% | → |
| 2024-02-20 | Medpace Investors, LLC | 10% Owner | Sell | 63,988 | $390.58 | $24,992,323.32 | -0.6% | → |
| 2023-12-15 | BURWIG SUSAN E | Exec. VP, Operations | Sell | 12,400 | $303.96 | $3,769,149.65 | -27.6% | → |
| 2023-12-01 | Troendle August J. | CEO | Sell | 24,039 | $273.26 | $6,568,897.14 | -0.4% | → |
| 2023-12-01 | Medpace Investors, LLC | - | Sell | 24,039 | $273.26 | $6,568,897.14 | -0.4% | → |